PCMC
ATOS icon

Planning Capital Management Corporation’s Atossa Therapeutics ATOS Stock Holding History

Planning Capital Management Corporation’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.52K Hold
67
– – ﹤0.01% 611
2024
Q2 		$1.19K Buy
+67
New +$1.48K ﹤0.01% 574

Other funds holding ATOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Planning Capital Management Corporation's ATOS Position: Q3 2024 in Review

Planning Capital Management Corporation held its Atossa Therapeutics (ATOS) position steady in Q3 2024 at 67 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Planning Capital Management Corporation first reported a position in ATOS in Q2 2024 and has held it in 2 quarters since. 86 funds tracked by Wall St. Rank hold ATOS as of Q3 2024.

  • Planning Capital Management Corporation held 67 shares of Atossa Therapeutics worth $1.52K as of Q3 2024.
  • Planning Capital Management Corporation left its Atossa Therapeutics share count unchanged in Q3 2024.
  • Atossa Therapeutics made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #611 holding.
  • Planning Capital Management Corporation first reported a position in Atossa Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 86 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.